Repligen | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Agilent USD 6.03B 129M 2025-01
Align Technology USD 3.85B 92.37M 2024-12
Bio Techne USD 2.08B 60.16M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Bruker USD 1.8B 28M 2024-12
Charles River Laboratories USD 3.46B 320.77M 2024-12
Danaher USD 49.54B 1.76B 2024-12
Dentsply International USD 1.94B 549M 2024-12
Exact Sciences USD 2.4B 808.26M 2024-12
General Electric USD 19.57B 691M 2024-12
Henry Schein USD 3.39B 110M 2024-12
Illumina USD 2.37B 248M 2024-12
IQVIA Holdings USD 6.07B 900M 2024-12
Mettler Toledo International USD -126890000 27.46M 2024-12
Myriad Genetics USD 701.1M 30.6M 2024-12
Patterson Companies USD 989.56M 26.55M 2025-01
Pfizer USD 88.2B 4.08B 2024-12
Repligen USD 2.02B 30.33M 2024-09
Revvity USD 7.67B 254.83M 2024-12
Standard Biotools USD 471.72M 17.61M 2024-12
Thermo Fisher Scientific USD 49.58B 592M 2024-12
Waters USD 1.83B 225.41M 2024-12
West Pharmaceutical Services USD 2.68B 69.8M 2024-12



Repligen Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.